Daniel Anderson

Professor
New IP

Department
Department of Chemical Engineering
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Sensors & Monitoring, Synthetic Biology, Biomanufacturing / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture / Therapeutics: Nucleic Acids, Small Molecules, Cell Based Therapy, Vaccines, Proteins & Antibodies, Regenerative Medicine / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Energy & Distribution: Electrochemical Devices / Biomaterials & Bioelectronics: Medical Device Coatings, Health Monitoring / Computer Science: Bioinformatics / Diagnostics: Assays

Pioneering smart materials for advancements in medical devices, drug delivery, and gene therapy, with a prolific publication record and significant impact across multiple disciplines.

Background and Experience

Daniel G. Anderson is a leading researcher in the fields of nanotherapeutics and biomaterials and has pioneered the development of smart materials. In addition to the Koch Institute, he holds appointments in MIT’s Department of Chemical Engineering, Institute for Medical Engineering and Science, and Harvard-MIT Division of Health Science and Technology. Anderson received a BA in mathematics and biology from the University of California at Santa Cruz and a PhD in molecular genetics from the University of California at Davis. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 500 papers, patents, and patent applications. He is the recipient of the 2023 Wilhelm Exner Medal.

Awards and Honors

  • Work has resulted in the publication of more than 500 papers, patents, and patent applications
  • Wilhelm Exner Medal | 2023

Technologies

Zwitterionic Polymer Functionalized Lipid Nanoparticles for Delivery of mRNA

Technology / Case number: #24662
Robert Langer / Allen Jiang / Sushil Lathwal / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Glucose- Responsive Microgels for Closed Loop Insulin Delivery

Technology / Case number: #15057J
Zhen Gu / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials
License

Ionizable Lipid OF-02 and its Use in mRNA Delivery

Technology / Case number: #17733
Joseph Dorkin / Owen Fenton / Kevin Kauffman / Rebecca McClellan / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery
License

Oligomeric Conjugates for siRNA Delivery and Glucose-Responsive Insulins

Technology / Case number: #15977J
Arturo Vegas / Rosemary Kanasty / Robert Langer / Daniel Anderson
Technology Areas: Diagnostics / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Biodegradable Lipids and Formulations for Intramuscular and Systemic Delivery of mRNA

Technology / Case number: #25351J
Arnab Rudra / Akash Gupta / Kaelan Reed / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Bioelectronic Devices to Support Transplanted Cells in Vivo for Encapsulated Cell Therapies

Technology / Case number: #23269J
Suman Bose / Robert Langer / Siddharth Krishnan / Matt Bochenek / Nima Khatib / Daniel Anderson
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Energy & Distribution / Therapeutics
Impact Areas: Healthy Living
License

Implantable Devices for the Ejected Delivery of Stable, Dry Powder Forms of Drugs

Technology / Case number: #24835J
Robert Langer / Arnab Rudra / Siddharth Krishnan / Nima Khatib / Laura OKeeffe / Daniel Anderson
Technology Areas: Biotechnology
Impact Areas: Healthy Living
License

Formulated, Biodegradable Polymeric Nanoparticles for Nucleic Acid Delivery to Non-Liver Targets

Technology / Case number: #19802
Kevin Kauffman / James Kaczmarek / Asha Patel / Luke Rhym / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Novel Ionizable Lipids Suitable For Lipid Nanoparticle Delivery of mRNA to Lung and Nasal Epithelium, As Well As Lung Endothelium

Technology / Case number: #23594Q
Luke Rhym / Allen Jiang / Jacob Witten / Idris Raji / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Delivery / Therapeutics
License

New Ionizable Lipid Library Suitable for Multiple Organ Targeting Derived From High Throughput Combinatorial Synthesis and Screening

Technology / Case number: #23406
Bowen Li / Akiva Gordon / Idris Raji / Daniel Anderson
Technology Areas: Artificial Intelligence (AI) and Machine Learning (ML) / Biotechnology / Drug Delivery / Therapeutics
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.